Europe and North America Digital Therapeutic (DTx) Market - Industry Trends and Forecast to 2030
Description
Europe and North America Digital Therapeutic (DTx) Market - Industry Trends and Forecast to 2030
Europe and North America Digital Therapeutic (DTx) Market, By Product Type (Hardware Product, Solutions/Software, Service), Application (Treatment/ Care-Related Applications, Preventive Applications), Purchase Mode (Group Purchase Organization, Individual), Sales Channel (B2B, B2C), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe)– Industry Trends & Forecast to 2030.
Market Definition
Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage, and avert a broad spectrum of behavioral, mental, and physical disorders. They are utilized alone or mixed with medications, devices, or other therapies to optimize patient care and health outcomes. Rising remote access to therapies clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment. It provides easy treatment as per the patient’s schedule and in the privacy and safety of their home environment. They are easily available and often accessible through patient-owned devices (smartphones, tablets). The rise in demand for digital therapeutics is increasing worldwide due to the prevalence of chronic diseases such as diabetes, and hypertension, among others, hence expected to drive market growth. Moreover, technological advancements have also provided the market with elevated growth.
Digital therapeutics (DTx) delivers evidence-based therapeutics to patients that are operated by high-quality software programs to forbid, cope, or nurse a medical disorder or disease. They are utilized individually or in recitals with medicaments, devices, or other remedies to revamp patient care and health upshot. DTx products subsume advanced technology best applications relating to design, clinical affirmations, usability, and data safety. They are corroborated by legislative bodies as required to hold up product asserts regarding peril, potency, and deliberated ply. DTx licenses patients, healthcare providers and payers with attainable tools for inscribing various conditions through high standard, sheltered and virtually data–driven medications.
Some of the market players provide products and services for chronic disorders, which are mainly used for the old age population. During the last few years, new innovative software has been coming up to let people get more attached to digital therapeutics for ease. A large number of market players are involved in providing services to uphold digital therapeutics, which paves the way for market growth.
Accounting for the diversity of products across the DTx industry, individual digital therapeutics have the potential to provide patients, clinicians, and payers with novel therapy options for unmet medical needs, be used independently or in conjunction with other therapies, enhance, support, or optimize current medical treatments, integrate into medical guidelines and best practices and enable the expansion of care outside of a traditional clinic setting.
Market Segmentation
Europe and North America digital therapeutic (DTx) market is categorized into five segments which are based on product and service type, application, purchase mode and sales channel and geography.
• On the basis of product and service type, Europe and North America digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service
• On the basis of application, Europe and North America digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications
• On the basis of purchase mode, the Europe and North America digital therapeutic (DTx) market is segmented into group purchase organizations and individual
• On the basis of sales channel, Europe and North America digital therapeutic (DTx) market is segmented into B2B and B2C
• On the basis of geography, the Europe and North America digital therapeutic (DTx) market is segmented into U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe
Market Players
Some of the key market players operating in the Europe and North America digital therapeutic (DTx) market are listed below:
• Noom
• Atentiv
• Cognoa
• Kaia Health
• Ginger
• Livongo Health
• Mango Health
• Natural Cycles
• Cognifit
• Fitbit, Inc.
• Omada Health
• Propeller Health
• Welldoc, Inc.
• Smart Patient GMBH
• Mindstrong Health
• Ayogo Health
• Better Therapeutics
• 2morrow
• Canary Health
• Click Therapeutics
• Pear Therapeutics
• Voluntis
• Akili Interactive Labs
• Samsung
• Resmed
• GAIA AG
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Europe and North America Digital Therapeutic (DTx) Market, By Product Type (Hardware Product, Solutions/Software, Service), Application (Treatment/ Care-Related Applications, Preventive Applications), Purchase Mode (Group Purchase Organization, Individual), Sales Channel (B2B, B2C), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe)– Industry Trends & Forecast to 2030.
Market Definition
Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage, and avert a broad spectrum of behavioral, mental, and physical disorders. They are utilized alone or mixed with medications, devices, or other therapies to optimize patient care and health outcomes. Rising remote access to therapies clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment. It provides easy treatment as per the patient’s schedule and in the privacy and safety of their home environment. They are easily available and often accessible through patient-owned devices (smartphones, tablets). The rise in demand for digital therapeutics is increasing worldwide due to the prevalence of chronic diseases such as diabetes, and hypertension, among others, hence expected to drive market growth. Moreover, technological advancements have also provided the market with elevated growth.
Digital therapeutics (DTx) delivers evidence-based therapeutics to patients that are operated by high-quality software programs to forbid, cope, or nurse a medical disorder or disease. They are utilized individually or in recitals with medicaments, devices, or other remedies to revamp patient care and health upshot. DTx products subsume advanced technology best applications relating to design, clinical affirmations, usability, and data safety. They are corroborated by legislative bodies as required to hold up product asserts regarding peril, potency, and deliberated ply. DTx licenses patients, healthcare providers and payers with attainable tools for inscribing various conditions through high standard, sheltered and virtually data–driven medications.
Some of the market players provide products and services for chronic disorders, which are mainly used for the old age population. During the last few years, new innovative software has been coming up to let people get more attached to digital therapeutics for ease. A large number of market players are involved in providing services to uphold digital therapeutics, which paves the way for market growth.
Accounting for the diversity of products across the DTx industry, individual digital therapeutics have the potential to provide patients, clinicians, and payers with novel therapy options for unmet medical needs, be used independently or in conjunction with other therapies, enhance, support, or optimize current medical treatments, integrate into medical guidelines and best practices and enable the expansion of care outside of a traditional clinic setting.
Market Segmentation
Europe and North America digital therapeutic (DTx) market is categorized into five segments which are based on product and service type, application, purchase mode and sales channel and geography.
• On the basis of product and service type, Europe and North America digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service
• On the basis of application, Europe and North America digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications
• On the basis of purchase mode, the Europe and North America digital therapeutic (DTx) market is segmented into group purchase organizations and individual
• On the basis of sales channel, Europe and North America digital therapeutic (DTx) market is segmented into B2B and B2C
• On the basis of geography, the Europe and North America digital therapeutic (DTx) market is segmented into U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe
Market Players
Some of the key market players operating in the Europe and North America digital therapeutic (DTx) market are listed below:
• Noom
• Atentiv
• Cognoa
• Kaia Health
• Ginger
• Livongo Health
• Mango Health
• Natural Cycles
• Cognifit
• Fitbit, Inc.
• Omada Health
• Propeller Health
• Welldoc, Inc.
• Smart Patient GMBH
• Mindstrong Health
• Ayogo Health
• Better Therapeutics
• 2morrow
• Canary Health
• Click Therapeutics
• Pear Therapeutics
• Voluntis
• Akili Interactive Labs
• Samsung
• Resmed
• GAIA AG
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
250 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Europe And North America Digital Therapeutic (Dtx) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product And Service Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market Application Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 5 Europe And North America Digital Therapeutic (Dtx) Market, Industry Insight
- Conclusion:
- 6 Europe And North America Digital Therapeutic (Dtx) Market, Regulation
- 7 Market Overview
- 7.1 Drivers
- 7.1.1 Rise In The Prevalence Of Chronic Diseases
- 7.1.2 Increase In Awareness By Government Agencies
- 7.1.3 Technological Advancement In Healthcare
- 7.1.4 Increased Number Of People Using Smartphones
- 7.1.5 Improved Quality Of Life
- 7.2 Restraints
- 7.2.1 Patient Information Privacy Policies
- 7.2.2 Digital Payment Associated With Digital Therapeutics
- 7.2.3 Underdeveloped Countries Lacking Smartphones And Internet Facilities
- 7.3 Opportunities
- 7.3.1 Rising Demand For Digital Therapeutics
- 7.3.2 Collaboration Between Companies To Provide Better Products/Services
- 7.3.3 Partnership Between Companies
- 7.3.4 Expansion And Launch Of Products
- 7.3.5 Events And Exhibition
- 7.3.6 Physician Adoption
- 7.4 Challenges
- 7.4.1 Clinical Validation
- 7.4.2 Regulatory Approval
- 7.4.3 Payer Reimbursement
- 8 Europe And North America Digital Therapeutic (Dtx) Market, By Product And Service Type
- 8.1 Overview
- 8.2 Solutions/Software
- 8.3 Hardware Products
- 8.4 Service
- 9 Europe And North America Digital Therapeutic (Dtx) Market, By Application
- 9.1 Overview
- 9.2 Treatment/Care-related Applications
- 9.2.1 Diabetis
- 9.2.1.1 Type 2
- 9.2.1.2 Type 1
- 9.2.2 Central Nervous System Disorders
- 9.2.2.1 Mental Health Disorder
- 9.2.2.2 Other Cns Disorders
- 9.2.3 Smoking Cessation
- 9.2.4 Chronic Respiratory Diseases
- 9.2.4.1 Asthma
- 9.2.4.2 Chronic Obstructive Pulmonary Disease
- 9.2.4.3 Others
- 9.2.5 Cardiovascular Diseases
- 9.2.5.1 Arrhytmia
- 9.2.5.2 Heart Failure
- 9.2.5.3 Others
- 9.2.6 Medication Adherence
- 9.2.7 Oncology
- 9.2.8 Gastrointestinal Disorders
- 9.2.9 Rehabilitation & Patient Care
- 9.2.10 Substance Use Disorders & Addiction Management
- 9.2.11 Other Treatment/Care-related Applications
- 9.3 Preventive Application
- 9.3.1 Heart Attacks
- 9.3.2 Prediabetes
- 9.3.3 Obesity
- 9.3.4 Nutrition
- 9.3.5 Lifestyle Management
- 9.3.6 Other Preventive Applications
- 10 Europe And North America Digital Therapeutic (Dtx) Market, By Purchase Mode
- 10.1 Overview
- 10.2 Group Purchase Organization
- 10.3 Solutions/Software
- 10.4 Hardware Products
- 10.5 Service
- 10.6 Individual
- 10.6.1 Solutions/Software
- 10.6.2 Hardware Products
- 10.6.3 Service
- 11 Europe And North America Digital Therapeutic (Dtx) Market, By Sales Channel
- 11.1 Overview
- 11.2 B2b
- 11.2.1 Payers
- 11.2.2 Employers
- 11.2.3 Pharmaceutical Companies
- 11.2.4 Providers
- 11.2.5 Other Buyers
- 11.3 B2c
- 11.3.1 Caregivers
- 11.3.2 Patients
- 12 Europe And North America Digital Therapeutic (Dtx) Market
- 12.1 North America
- 12.1.1 U.S.
- 12.1.2 Canada
- 12.1.3 Mexico
- 12.2 Europe
- 12.2.1 Germany
- 12.2.2 France
- 12.2.3 Italy
- 12.2.4 U.K.
- 12.2.5 Spain
- 12.2.6 Switzerland
- 12.2.7 Ireland
- 12.2.8 Netherlands
- 12.2.9 Russia
- 12.2.10 Hungary
- 12.2.11 Turkey
- 12.2.12 Austria
- 12.2.13 Poland
- 12.2.14 Norway
- 12.2.15 Lithuania
- 12.2.16 Rest Of Europe
- 13 Europe And North America Digital Therapeutic (Dtx) Market, Company Landscape
- 13.1 Company Share Analysis: North America
- 13.2 Company Share Analysis: Europe
- 14 Swot Analysis
- 15 Company Profile
- 15.1 Samsung
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Product Portfolio
- 15.1.4 Recent Development
- 15.2 Voluntis
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Product Portfolio
- 15.2.4 Recent Development
- 15.3 Noom, Inc.
- 15.3.1 Company Snapshot
- 15.3.2 Product Portfolio
- 15.3.3 Recent Development
- 15.4 Fitbit, Inc.
- 15.4.1 Company Snapshot
- 15.4.2 Product Portfolio
- 15.4.3 Recent Developments
- 15.5 Livongo
- 15.5.1 Company Snapshot
- 15.5.2 Revenue Analysis
- 15.5.3 Product Portfolio
- 15.5.4 Recent Development
- 15.6 Akili Interactive Labs, Inc.
- 15.6.1 Company Snapshot
- 15.6.2 Revenue Analysis
- 15.6.3 Product Portfolio
- 15.6.4 Recent Developments
- 15.7 Atentiv
- 15.7.1 Company Snapshot
- 15.7.2 Product Portfolio
- 15.7.3 Recent Developments
- 15.8 Ayogo Health Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Product Portfolio
- 15.8.3 Recent Development
- 15.9 Better Therapeutics, Inc
- 15.9.1 Company Snapshot
- 15.9.2 Product Portfolio
- 15.9.3 Recent Developments
- 15.10 Canary Health
- 15.10.1 Company Snapshot
- 15.10.2 Product Portfolio
- 15.10.3 Recent Development
- 15.11 Cognoa
- 15.11.1 Company Snapshot
- 15.11.2 Product Portfolio
- 15.11.3 Recent Developments
- 15.12 Cognifit
- 15.12.1 Company Snapshot
- 15.12.2 Product Portfolio
- 15.12.3 Recent Development
- 15.13 Click Therapeutics, Inc.
- 15.13.1 Company Snapshot
- 15.13.2 Product Portfolio
- 15.13.3 Recent Development
- 15.14 Ginger
- 15.14.1 Company Snapshot
- 15.14.2 Product Portfolio
- 15.14.3 Recent Development
- 15.15 Gaia Ag
- 15.15.1 Company Snapshot
- 15.15.2 Product Portfolio
- 15.15.3 Recent Development
- 15.16 Kaia Health
- 15.16.1 Company Snapshot
- 15.16.2 Product Portfolio
- 15.16.3 Recent Developments
- 15.17 Mango Health
- 15.17.1 Company Snapshot
- 15.17.2 Product Portfolio
- 15.17.3 Recent Development
- 15.18 Mindstrong Health
- 15.18.1 Company Snapshot
- 15.18.2 Product Portfolio
- 15.18.3 Recent Development
- 15.19 2morrow Inc.
- 15.19.1 Company Snapshot
- 15.19.2 Product Portfolio
- 15.19.3 Recent Developments
- 15.20 Natural Cycles Usa Corp
- 15.20.1 Company Snapshot
- 15.20.2 Product Portfolio
- 15.20.3 Recent Development
- 15.21 Omada Health, Inc.
- 15.21.1 Company Snapshot
- 15.21.2 Product Portfolio
- 15.21.3 Recent Developments
- 15.22 Pear Therapeutics, Inc.
- 15.22.1 Company Snapshot
- 15.22.2 Product Portfolio
- 15.22.3 Recent Development
- 15.23 Resmed
- 15.23.1 Company Snapshot
- 15.23.2 Revenue Analysis
- 15.23.3 Product Portfolio
- 15.23.4 Recent Development
- 15.24 Smartpatient Gmbh
- 15.24.1 Company Snapshot
- 15.24.2 Product Portfolio
- 15.24.3 Recent Development
- 15.25 Welldoc, Inc.
- 15.25.1 Company Snapshot
- 15.25.2 Product Portfolio
- 15.25.3 Recent Developments
- 16 Questionnaire
- 17 Related Reports 250
- List Of Tables
- Table 1 Regulatory Framework
- Table 2 Europe Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 3 North America Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 4 Europe Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 5 North America Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 6 Europe Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 7 North America Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 8 Europe Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 9 North America Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 10 Europe Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 11 North America Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 12 Europe Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 13 North America Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 14 Europe Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 15 North America Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 16 Europe Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 17 North America Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 18 Europe Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 19 North America Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 20 Europe Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 21 North America Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 22 Europe Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 23 North America Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 24 Europe Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 25 North America Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 26 Europe B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 27 North America B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 28 Europe B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 29 North America B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 30 North America Digital Therapeutic (Dtx) Market, By Country, 2021-2030 (Usd Million)
- Table 31 U.S. Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 32 U.S. Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 33 U.S. Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 34 U.S. Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 35 U.S. Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 36 U.S. Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 37 U.S. Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 38 U.S. Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 39 U.S. Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 40 U.S. Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 41 U.S. Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 42 U.S. Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 43 U.S. B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 44 U.S. B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 45 Canada Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 46 Canada Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 47 Canada Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 48 Canada Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 49 Canada Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 50 Canada Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 51 Canada Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 52 Canada Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 53 Canada Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 54 Canada Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 55 Canada Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 56 Canada Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 57 Canada B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 58 Canada B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 59 Mexico Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 60 Mexico Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 61 Mexico Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 62 Mexico Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 63 Mexico Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 64 Mexico Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 65 Mexico Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 66 Mexico Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 67 Mexico Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 68 Mexico Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 69 Mexico Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 70 Mexico Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 71 Mexico B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 72 Mexico B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 73 Europe Digital Therapeutic (Dtx) Market, By Country, 2021-2030 (Usd Million)
- Table 74 Germany Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 75 Germany Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 76 Germany Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 77 Germany Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 78 Germany Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 79 Germany Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 80 Germany Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 81 Germany Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 82 Germany Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 83 Germany Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 84 Germany Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 85 Germany Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 86 Germany B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 87 Germany B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 88 France Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 89 France Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 90 France Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 91 France Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 92 France Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 93 France Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 94 France Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 95 France Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 96 France Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 97 France Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 98 France Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 99 France Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 100 France B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 101 France B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 102 Italy Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 103 Italy Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 104 Italy Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 105 Italy Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 106 Italy Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 107 Italy Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 108 Italy Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 109 Italy Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 110 Italy Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 111 Italy Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 112 Italy Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 113 Italy Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 114 Italy B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 115 Italy B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 116 U.K. Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 117 U.K. Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 118 U.K. Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 119 U.K. Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 120 U.K. Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 121 U.K. Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 122 U.K. Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 123 U.K. Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 124 U.K. Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 125 U.K. Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 126 U.K. Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 127 U.K. Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 128 U.K. B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 129 U.K. B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 130 Spain Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 131 Spain Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 132 Spain Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 133 Spain Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 134 Spain Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 135 Spain Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 136 Spain Diabetes In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 137 Spain Preventive Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 138 Spain Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 139 Spain Group Purchase Organization In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 140 Spain Individual In Digital Therapeutic (Dtx) Market, By Purchase Mode, 2021-2030 (Usd Million)
- Table 141 Spain Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 142 Spain B2b In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 143 Spain B2c In Digital Therapeutic (Dtx) Market, By Sales Channel, 2021-2030 (Usd Million)
- Table 144 Switzerland Digital Therapeutic (Dtx) Market, By Product And Service Type, 2021-2030 (Usd Million)
- Table 145 Switzerland Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 146 Switzerland Treatment/Care-related Applications In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 147 Switzerland Central Nervous System Disorders In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 148 Switzerland Cardiovascular Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- Table 149 Switzerland Chronic Respiratory Diseases In Digital Therapeutic (Dtx) Market, By Application, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Europe And North America Digital Therapeutic (Dtx) Market: Segmentation
- Figure 2 Europe And North America Digital Therapeutic (Dtx) Market: Data Triangulation
- Figure 3 Europe And North America Digital Therapeutic (Dtx) Market: Droc Analysis
- Figure 4 Europe And North America Digital Therapeutic (Dtx) Market: Global Vs Regional Market Analysis
- Figure 5 Europe And North America Digital Therapeutic (Dtx) Market: Company Research Analysis
- Figure 6 Europe And North America Digital Therapeutic (Dtx) Market: Multivariate Modelling
- Figure 7 Europe And North America Digital Therapeutic (Dtx) Market: Interview Demographics
- Figure 8 Europe And North America Digital Therapeutic (Dtx) Market: Dbmr Market Position Grid
- Figure 9 Europe And North America Digital Therapeutic (Dtx) Market: Market Application Coverage Grid
- Figure 10 Europe And North America Digital Therapeutic (Dtx) Market: Vendor Share Analysis
- Figure 11 Europe And North America Digital Therapeutic (Dtx) Market: Segmentation
- Figure 12 The Increasing Demand For Digital Therapeutics Is Increasing Worldwide Due To The Prevalence Of Chronic Diseases Is Expected To Drive The Market Growth In The Forecast Period Of 2023 To 2030.
- Figure 13 Solutions/ Softwares Segment Is Expected To Account For The Largest Share Of The North America Digital Therapeutic (Dtx) Market In 2023 & 2030
- Figure 14 Solutions/ Softwares Segment Is Expected To Account For The Largest Share Of The Europe Digital Therapeutic (Dtx) Market In 2023 & 2030
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Europe And North America Digital Therapeutic (Dtx) Market
- Figure 16 Europe Digital Therapeutic (Dtx) Market: By Product And Service Type, 2022
- Figure 17 Europe Digital Therapeutic (Dtx) Market: By Product And Service Type, 2023-2030 (Usd Million)
- Figure 18 Europe Digital Therapeutic (Dtx) Market: By Product And Service Type, Cagr (2023-2030)
- Figure 19 Europe Digital Therapeutic (Dtx) Market: By Product And Service Type, Lifeline Curve
- Figure 20 North America Digital Therapeutic (Dtx) Market: By Product And Service Type, 2022
- Figure 21 North America Digital Therapeutic (Dtx) Market: By Product And Service Type, 2023-2030 (Usd Million)
- Figure 22 North America Digital Therapeutic (Dtx) Market: By Product And Service Type, Cagr (2023-2030)
- Figure 23 North America Digital Therapeutic (Dtx) Market: By Product And Service Type, Lifeline Curve
- Figure 24 Europe Digital Therapeutic (Dtx) Market: By Application, 2022
- Figure 25 Europe Digital Therapeutic (Dtx) Market: By Application, 2023-2030 (Usd Million)
- Figure 26 Europe Digital Therapeutic (Dtx) Market: By Application, Cagr (2023-2030)
- Figure 27 Europe Digital Therapeutic (Dtx) Market: By Application, Lifeline Curve
- Figure 28 North America Digital Therapeutic (Dtx) Market: By Application, 2022
- Figure 29 North America Digital Therapeutic (Dtx) Market: By Application, 2023-2030 (Usd Million)
- Figure 30 North America Digital Therapeutic (Dtx) Market: By Application, Cagr (2023-2030)
- Figure 31 North America Digital Therapeutic (Dtx) Market: By Application, Lifeline Curve
- Figure 32 Europe Digital Therapeutic (Dtx) Market: By Purchase Mode, 2022
- Figure 33 Europe Digital Therapeutic (Dtx) Market: By Purchase Mode, 2023-2030 (Usd Million)
- Figure 34 Europe Digital Therapeutic (Dtx) Market: By Purchase Mode, Cagr (2023-2030)
- Figure 35 Europe Digital Therapeutic (Dtx) Market: By Purchase Mode, Lifeline Curve
- Figure 36 North America Digital Therapeutic (Dtx) Market: By Purchase Mode, 2022
- Figure 37 North America Digital Therapeutic (Dtx) Market: By Purchase Mode, 2023-2030 (Usd Million)
- Figure 38 North America Digital Therapeutic (Dtx) Market: By Purchase Mode, Cagr (2023-2030)
- Figure 39 North America Digital Therapeutic (Dtx) Market: By Purchase Mode, Lifeline Curve
- Figure 40 Europe Digital Therapeutic (Dtx) Market: By Sales Channel, 2022
- Figure 41 Europe Digital Therapeutic (Dtx) Market: By Sales Channel, 2023-2030 (Usd Million)
- Figure 42 Europe Digital Therapeutic (Dtx) Market: By Sales Channel, Cagr (2023-2030)
- Figure 43 Europe Digital Therapeutic (Dtx) Market: By Sales Channel, Lifeline Curve
- Figure 44 North America Digital Therapeutic (Dtx) Market: By Sales Channel, 2022
- Figure 45 North America Digital Therapeutic (Dtx) Market: By Sales Channel, 2023-2030 (Usd Million)
- Figure 46 North America Digital Therapeutic (Dtx) Market: By Sales Channel, Cagr (2023-2030)
- Figure 47 North America Digital Therapeutic (Dtx) Market: By Sales Channel, Lifeline Curve
- Figure 48 North America Digital Therapeutic (Dtx) Market: Snapshot (2022)
- Figure 49 North America Digital Therapeutic (Dtx) Market: By Country (2022)
- Figure 50 North America Digital Therapeutic (Dtx) Market: By Country (2023 & 2030)
- Figure 51 North America Digital Therapeutic (Dtx) Market: By Country (2022 & 2030)
- Figure 52 North America Digital Therapeutic (Dtx) Market: Product And Service Type (2023-2030)
- Figure 53 Europe Digital Therapeutic (Dtx) Market: Snapshot (2022)
- Figure 54 Europe Digital Therapeutic (Dtx) Market: By Country (2022)
- Figure 55 Europe Digital Therapeutic (Dtx) Market: By Country (2023 & 2030)
- Figure 56 Europe Digital Therapeutic (Dtx) Market: By Country (2022 & 2030)
- Figure 57 Europe Digital Therapeutic (Dtx) Market: Product And Service Type (2023-2030)
- Figure 58 North America Digital Therapeutic (Dtx) Market: Company Share 2022 (%)
- Figure 59 Europe Digital Therapeutic (Dtx) Market: Company Share 2022 (%) 211
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
